Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors Grant US-11851434-B2 United States of America 26 Dec 2023
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-11648243-B2 United States of America 16 May 2023
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors Grant US-11603374-B2 United States of America 14 Mar 2023
Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors Grant US-11524963-B2 United States of America 13 Dec 2022
Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors Grant US-11472802-B2 United States of America 18 Oct 2022
Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors Grant US-11168090-B2 United States of America 09 Nov 2021
Macrocyclic compounds as ROS1 kinase inhibitors Grant US-10966985-B2 United States of America 06 Apr 2021
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10953005-B1 United States of America 23 Mar 2021
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10881652-B2 United States of America 05 Jan 2021
Macrocyclic compounds as TRK kinase inhibitors Grant US-10647730-B2 United States of America 12 May 2020
FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS Application WO-2020055672-A1 World Intellectual Property Organisation (WIPO) 19 Mar 2020
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10555944-B2 United States of America 11 Feb 2020
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10441581-B2 United States of America 15 Oct 2019
SUBSTITUTED PYRAZOLYL[4,3-C]PYRIDINECOMPOUNDS AS RET KINASE INHIBITORS Application WO-2019143994-A1 World Intellectual Property Organisation (WIPO) 25 Jul 2019
SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES COMPOUNDS AS RET KINASE INHIBITORS Application WO-2019143977-A1 World Intellectual Property Organisation (WIPO) 25 Jul 2019
CRYSTALLINE FORMS Application WO-2019075108-A1 World Intellectual Property Organisation (WIPO) 18 Apr 2019
FORMULATIONS COMPRISING 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHY… Application WO-2019075114-A1 World Intellectual Property Organisation (WIPO) 18 Apr 2019
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10174027-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10174028-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10172851-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10172845-B2 United States of America 08 Jan 2019
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10144734-B2 United States of America 04 Dec 2018
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10137124-B2 United States of America 27 Nov 2018
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant US-10138243-B2 United States of America 27 Nov 2018
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10112942-B2 United States of America 30 Oct 2018
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS Application WO-2018136661-A1 World Intellectual Property Organisation (WIPO) 26 Jul 2018
RET INHIBITORS Application WO-2018136663-A1 World Intellectual Property Organisation (WIPO) 26 Jul 2018
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant US-10023570-B2 United States of America 17 Jul 2018